Efficacy News and Research

RSS
Neurologix reports lower net loss of $3.5M for first-quarter 2010

Neurologix reports lower net loss of $3.5M for first-quarter 2010

Immunosuppressive drug sirolimus improves kidney health of patients with ADPKD: Study

Immunosuppressive drug sirolimus improves kidney health of patients with ADPKD: Study

caprotec bioanalytics closes EUR 4 million Series B Financing Round

caprotec bioanalytics closes EUR 4 million Series B Financing Round

Phase IIb trail results of epratuzumab in lupus patients to be presented at EULAR 2010

Phase IIb trail results of epratuzumab in lupus patients to be presented at EULAR 2010

Transdel Pharmaceuticals reports lower net loss of $0.9 million for first-quarter 2010

Transdel Pharmaceuticals reports lower net loss of $0.9 million for first-quarter 2010

Study results of Cameron Health's S-ICD- System published online in NEJM

Study results of Cameron Health's S-ICD- System published online in NEJM

Chimerix commences first-in-human study of CMX157 for HIV

Chimerix commences first-in-human study of CMX157 for HIV

Rexahn Pharmaceuticals announces Phase IIb clinical trial of Zoraxel for ED

Rexahn Pharmaceuticals announces Phase IIb clinical trial of Zoraxel for ED

ARYx Therapeutics decreases first-quarter net loss to $6.4 million

ARYx Therapeutics decreases first-quarter net loss to $6.4 million

Stereotaxis to be featured prominently in 31st HRS

Stereotaxis to be featured prominently in 31st HRS

Trubion Pharmaceuticals to present promising data from Phase 1 studies of  SBI-087,  SBI-087

Trubion Pharmaceuticals to present promising data from Phase 1 studies of SBI-087, SBI-087

Advances in vaccine delivery and efficacy discussed at National Immunization Conference

Advances in vaccine delivery and efficacy discussed at National Immunization Conference

Amarin reports cash balance of $44 million for first-quarter 2010

Amarin reports cash balance of $44 million for first-quarter 2010

Sex can affect frequency and severity of adverse effects of vaccination

Sex can affect frequency and severity of adverse effects of vaccination

Regeneron Pharmaceuticals provides update on REGN727, REGN475 antibody product candidates

Regeneron Pharmaceuticals provides update on REGN727, REGN475 antibody product candidates

CTI to conduct phase II study of pixantrone in patients with HER2-negative breast cancer

CTI to conduct phase II study of pixantrone in patients with HER2-negative breast cancer

BSX receives CE Mark approval for TAXUS Element Paclitaxel-Eluting Coronary Stent System

BSX receives CE Mark approval for TAXUS Element Paclitaxel-Eluting Coronary Stent System

Boston Scientific receives CE Mark approval for TAXUS Element Paclitaxel-Eluting Coronary Stent System

Boston Scientific receives CE Mark approval for TAXUS Element Paclitaxel-Eluting Coronary Stent System

Avexa halts HIV drug trials

Avexa halts HIV drug trials

RBC Life Sciences first-quarter net sales increase 16% to $7.0M

RBC Life Sciences first-quarter net sales increase 16% to $7.0M

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.